immunotherapy biomarkers in neoadjuvant breast cancer
Published 2 months ago • 75 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
0:55
prognostic biomarkers of immunotherapy efficacy in breast cancer
-
1:00
utilizing neoadjuvant immunotherapies in patients with er , her2- primary breast cancer
-
1:03
elucidating immunotherapy biomarkers for breast cancer
-
7:26
i-spy 2: immunotherapy biomarkers in early breast cancer
-
2:13
changes in tumour biomarkers after neoadjuvant chemotherapy in breast cancer
-
1:55
predictive biomarkers in breast cancer
-
2:39
the role of biomarkers in guiding treatment for early-stage breast cancer
-
7:09
personalizing immunotherapy beyond pdl1 expression
-
4:38
exciting updates in biomarkers of response to neoadjuvant chemotherapy
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
2:15
i-spy2.2: emerging biomarkers in breast cancer
-
2:28
important biomarkers in luminal type breast cancer and dcis
-
6:45
innovative biomarker approaches in breast cancer therapy
-
2:42
biomarker-driven therapies for triple-negative breast cancer
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
1:29
the challenges of using biomarkers for immunotherapy
-
1:08
the role of neoadjuvant immunotherapy in msi-high gastric cancer
-
3:09
keynote-522: neoadjuvant and adjuvant pembrolizumab for early tnbc
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy